Announcement Regarding Establishment of Medical Business Venture Company between Olympus and Sony

Published on:

Olympus Corporation (“Olympus”) and Sony Corporation (“Sony”) today announced that the two parties recently received all necessary regulatory approvals and now expect to establish the medical business venture company (the “medical business venture”) on April 16, 2013 in accordance with the business alliance agreement executed on September 28, 2012.

Olympus and Sony continue to work together with the goal of creating ground-breaking products and solutions by combining their respective technologies and know-how through the medical business venture.

Related Content

Warning: Sidelined reactor could trigger medical isotope shortage
Malpractice watchers: Radiologists, imaging societies should bone up on the ‘science of visual perception’
ACR shares guidance for radiology providers facing IV supply shortages after hurricane
Incidental finding characteristics that warrant communication
AI implementation improves when radiology staff concerns are considered
Hospital organization sees impressive returns from POCUS integration

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.